Genpact (G) legal officer files insider report with no share holdings

Rhea-AI Filing Summary

Genpact LTD disclosed an insider ownership report for one of its senior executives. The filing relates to Sydney Schaub, who serves as SVP and Chief Legal Officer, with an event date of 12/08/2025.

According to the filing, no Genpact securities are beneficially owned, as noted in the explanation of responses. The form is filed for a single reporting person and is signed by Thomas D. Scholtes as attorney-in-fact for Sydney Schaub under a referenced power of attorney (Exhibit 24.1).

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Schaub Sydney

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NY 10175

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/08/2025

3. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP and Chief Legal Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24.1 - Power of Attorney

No securities are beneficially owned.

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Sydney Schaub	12/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is the reporting person in this Genpact (G) insider filing?

The reporting person is Sydney Schaub, who is identified as an officer of Genpact LTD, serving as SVP and Chief Legal Officer.

What date does this Genpact (G) insider ownership information reflect?

The insider ownership information relates to the event date of 12/08/2025, as stated in the filing.

What does the filing say about Sydney Schaub’s beneficial ownership of Genpact securities?

The explanation of responses states that no securities are beneficially owned by the reporting person.

Is this Genpact (G) insider filing for one person or multiple reporting persons?

The document indicates that the form is filed by one reporting person, not by a group.

Who signed this insider filing on behalf of the reporting person for Genpact (G)?

The filing is signed by /s/ Thomas D. Scholtes, acting as attorney-in-fact for Sydney Schaub, with a referenced Power of Attorney (Exhibit 24.1).

Are any derivative or non-derivative Genpact securities reported as owned in this filing?

The tables for non-derivative and derivative securities are included, and the remarks clarify that no securities are beneficially owned.